OBJECTIVES: To test for differences in overall and recurrence-free survival between laparoscopic and open surgical approaches in patients undergoing radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). MATERIALS AND METHODS: We retrospectively identified patients treated for UTUC from 2010 to 2020 from our institutional database. Patients undergoing laparoscopic or open RNU with no suspicion of metastasis (cM0) were for the current study population. Patients with suspected metastases at diagnosis (cM1) or those undergoing other surgical treatments were excluded. Tabulation was performed according to the laparoscopic versus open surgical approach. Kaplan-Meier plots were used to test for differences in overall and recurrence-free survival with regard to the surgical approach. Furthermore, separate Kaplan-Meier plots were used to test the effect of preoperative ureterorenoscopy on overall and recurrence-free survival within the overall study cohort. RESULTS: Of the 59 patients who underwent nephroureterectomy, 29% (n = 17) underwent laparoscopic nephroureterectomy, whereas 71% (n = 42) underwent open nephroureterectomy. Patient and tumor characteristics were comparable between groups (p ≥ 0.2). The median overall survival was 93 and 73 months in the laparoscopic nephroureterectomy group compared to the open nephroureterectomy group (p = 0.5), respectively. The median recurrence-free survival did not differ between open and laparoscopic nephroureterectomies (73 months for both groups; p = 0.9). Furthermore, the median overall and recurrence-free survival rates did not differ between patients treated with and without preoperative ureterorenoscopy. CONCLUSIONS: The results of this retrospective, single-center institution showed that overall and recurrence-free survival rates did not differ between patients with UTUC treated with laparoscopic and open RNU. Furthermore, preoperative ureterorenoscopy before RNU was not associated with higher overall or recurrence-free survival rates.

Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montreal Health Center Montreal Quebec Canada

Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria

Department of Urology University Hospital Frankfurt Goethe University Frankfurt am Main Frankfurt am Main Germany

Department of Urology University of Texas Southwestern Dallas TX USA

Department of Urology Weill Cornell Medical College New York NY USA

Division of Urology Department of Special Surgery Jordan University Hospital The University of Jordan Amman Jordan

Institute for Urology and Reproductive Health 1 M Sechenov 1st Moscow State Medical University Moscow Russia

Martini Klinik Prostate Cancer Center University Hospital Hamburg Eppendorf Hamburg Germany

Zobrazit více v PubMed

Rouprêt M Babjuk M Burger M, et al. . European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 2021;79(1):62–79. PubMed

Piszczek R Nowak Ł Krajewski W, et al. . Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: An updated meta-analysis. World J Surg Onc 2021;19(1):129. PubMed PMC

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7–34. PubMed

Soualhi A Rammant E George G, et al. . The incidence and prevalence of upper tract urothelial carcinoma: A systematic review. BMC Urol 2021;21(1):110. PubMed PMC

Baard J Cormio L Cavadas V, et al. . Contemporary patterns of presentation, diagnostics and management of upper tract urothelial cancer in 101 centres: The Clinical Research Office of the Endourological Society Global Upper Tract Urothelial Carcinoma Registry. Curr Opin Urol 2021;31(4):354–362. PubMed

Margulis V Shariat SF Matin SF, et al. . Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration. Cancer 2009;115(6):1224–1233. PubMed

Collà Ruvolo C Nocera L Stolzenbach LF, et al. . Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma. Eur Urol Oncol 2021;4(5):792–801. PubMed

Hanna N Sun M Trinh Q-D, et al. . Propensity-score–matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: A national series. Eur Urol 2012;61(4):715–721. PubMed

Sugihara T Yasunaga H Yu C, et al. . Perioperative outcome comparisons between open and laparoscopic nephroureterectomy among a population-based cohort from 2010 to 2012. J Endourol 2015;29(7):770–776. PubMed

Veccia A Antonelli A Francavilla S, et al. . Robotic versus other nephroureterectomy techniques: A systematic review and meta-analysis of over 87,000 cases. World J Urol 2020;38(4):845–852. PubMed

Kim HS, Ku JH, Jeong CW, Kwak C, Kim HH. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma. World J Urol 2016;34(6):859–869. PubMed

Shigeta K Kikuchi E Abe T, et al. . Long-term oncologic outcomes of laparoscopic versus open radical nephroureterectomy for patients with T3N0M0 upper tract urothelial carcinoma: A multicenter cohort study with adjustment by propensity score matching. Ann Surg Oncol 2019;26(11):3774–3781. PubMed

Simone G Papalia R Guaglianone S, et al. . Laparoscopic versus open nephroureterectomy: Perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 2009;56(3):520–526. PubMed

Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epidemiol 2004;57(12):1288–1294. PubMed

R Development Core Team . R: A Language and Environment for Statistical Computing. Vienna, Austria: R Development Core Team. Available at: https://wwwr-projectorg2017. 2017. Accessed March 15, 2022.

Wang M Ren X Wang G, et al. . Construction of a survival prediction model for high-and low-grade UTUC after tumor resection based on ‘SEER database’: A multicenter study. BMC Cancer 2021;21(1):999. PubMed PMC

Collà Ruvolo C Wenzel M Nocera L, et al. . The effect of race on stage at presentation and survival in upper tract urothelial carcinoma. Urol Oncol 2021;39(11):788.e7–788.e13. PubMed

Deuker M Stolzenbach LF Collà Ruvolo C, et al. . Upper urinary tract tumors: Variant histology versus urothelial carcinoma. Clin Genitourin Cancer 2021;19(2):117–124. PubMed

Liu F Guo W Zhou X, et al. . Laparoscopic versus open nephroureterectomy for upper urinary tract urothelial carcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97(35):e11954. PubMed PMC

Xylinas E Kluth L Passoni N, et al. . Prediction of intravesical recurrence after radical nephroureterectomy: Development of a clinical decision-making tool. Eur Urol 2014;65(3):650–658. PubMed

Rouprêt M Smyth G Irani J, et al. . Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol 2009;27(1):81–88. PubMed

İzol V Deger M Ozden E, et al. . The effect of diagnostic ureterorenoscopy on intravesical recurrence in patients undergoing nephroureterectomy for primary upper tract urinary carcinoma. Urol Int 2021;105(3–4):291–297. PubMed

Kluth LA Xylinas E Kent M, et al. . Predictors of survival in patients with disease recurrence after radical nephroureterectomy. BJU Int 2014;113(6):911–917. PubMed

Lee SM, McKay A, Grimes N, Umez-Eronini N, Aboumarzouk OM. Distal ureter management during nephroureterectomy: Evidence from a systematic review and cumulative analysis. J Endourol 2019;33(4):263–273. PubMed

Xylinas E Rink M Cha EK, et al. . Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 2014;65(1):210–217. PubMed

Pizzighella M Bruyere F Peyronnet B, et al. . The management of distal ureter during radical nephroureterectomy does not influence bladder recurrence. J Endourol 2022;36(1):77–82. PubMed